Clearpoint Neuro Inc (CLPT) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access CLPT Annual Balance Sheets →
Quarterly balance sheet trends provide context on Clearpoint Neuro Inc's liquidity, leverage, and long-term financial structure.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent29.36
Cash & Short-term Investments29.00
Accounts receivable8.40
Other Receivables0.96
Inventories8.81
Other Current Assets0.00
Prepaid Expense And Other Assets Current2.36
Total Current Assets48.93
Equipment/Property/Plant Net2.99
Goodwill net7.47
Intangible Assets12.92
Other Assets, Noncurrent14.44
Operating Lease Right Of Use Asset13.09
Total Assets86.74
Liabilities
Accounts Payable, Current AC2.15
Employee-related Liabilities, Current AC4.14
Other Liabilities, Current4.02
Total Current Liabilities10.31
Long-term debt50.23
Total Long-term Debt50.23
Other liabilities, Noncurrent15.42
ContractWithCustomerLiabilityNoncurrent0.61
Operating Lease Liability Current0.23
Total Liabilities75.97
Stockholders' Equity
Common Stock Value2.87
Additional Paid In Capital Common Stock245.70
Retained Earnings / Accumulated Deficit-237.80
Other Equity0.00
Common Stockholder's Equity10.78
Total Stockholder's Equity10.78
Liabilities & Stockholder's Equity86.74
4 historic quarters locked

Sign in to unlock the full Clearpoint Neuro Inc balance sheet history.

About Clearpoint Neuro Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-330842

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.